Permalink to Injectable biochip for SARS-CoV-2 detection near FDA approval

Injectable biochip for SARS-CoV-2 detection near FDA approval

The Silicon Valley company, Profusa,1 in partnership with the U.S. Defense Advanced Research Projects Agency (DARPA),2 has created an injectable biosensor capable of detecting the presence of an infection in your body.3 In early August 2019, months before COVID-19 became a household word, DARPA granted Profusa additional funding “to develop an early identification system to detect disease outbreaks, biological attacks and pandemics up to three weeks earlier than current methods.”4 As discussed in “Will New COVID Vaccine Make You Transhuman?” we appear to stand at the doorway of a brave new world in which man is increasingly merged with technology and artificial intelligence, and COVID-19 may well be the key that opens that door, in more ways than one.